nextaevolux.com
nextaevolux.com
  • Home
  • About us
  • Research Laboratory
  • Patent
  • Featured Technologies
  • Publications
  • State Transition Theory
  • Scientific Roadmap
  • Founder Profile
  • More
    • Home
    • About us
    • Research Laboratory
    • Patent
    • Featured Technologies
    • Publications
    • State Transition Theory
    • Scientific Roadmap
    • Founder Profile
  • Home
  • About us
  • Research Laboratory
  • Patent
  • Featured Technologies
  • Publications
  • State Transition Theory
  • Scientific Roadmap
  • Founder Profile

Technology Platforms & Research Programs

Selected Research and Technology Platforms

Platform technologies supporting cellular resilience, healthy aging, and regenerative biology research.

Next Aevolux Laboratories has developed biologically derived delivery platforms designed for transient and controlled delivery of reprogramming-associated nucleic acids, supporting cellular resilience and regenerative biology research.


Stepwise process of exosome engineering from stem cells to engineered exosomes.

Exosome Delivery Platform

Development of biologically derived extracellular vesicle delivery systems designed to support controlled and transient modulation of cellular pathways associated with healthy aging, cellular resilience, and regenerative biology.

Diagram illustrating engineered exosome delivery and transient gene modulation in cells.

Transient Expression Technologies

Investigating controlled transient expression systems for cellular function research.

Future Development Pipeline NA-OSK302™ Research Program

NA-OSK302™ is part of the laboratory's future research program focused on investigating cellular reprogramming mechanisms and their potential scientific applications. Current activities are limited to basic research and technology development.

Infographic illustrating engineered exosomes for targeted cellular delivery and modulation.

Delivery System Components

Scalable delivery platform components designed for research and innovation.
 

Patent Portfolio

Patent Application No. 19/307,922

Patent Application No. 19/307,922

Patent Application No. 19/307,922

  • Encapsulated Delivery System and Method for Enhanced Bioactive Compound Delivery
  • Status: Pending

Patent Application No. 19/428,107

Patent Application No. 19/307,922

Patent Application No. 19/307,922

  • Advanced Multi-Trigger Release Platform
  • Status: Pending

Patent Application No. 19/428,192

Patent Application No. 19/307,922

Patent Application No. 19/428,192

  • Enhanced Cellular Delivery Technologies
  • Status: Pending

Future Development

Next Aevolux Laboratories will continue advancing interdisciplinary research in healthy aging, cellular resilience, regenerative biology, advanced delivery systems, and AI-driven innovation.


All activities are conducted exclusively for scientific research, technology development, and educational purposes.


NEXT AEVOLUX™

Research • Innovation • Regenerative Biology

contact@nextaevolux.com

© 2026 Next Aevolux Laboratories. All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept